Don't want ads? Subscribe or login now.

Merck, Bayer Target Watson Over Generic Beyaz Birth Control

By Erica Teichert · February 10, 2012, 8:45 PM EST

Merck & Cie and Bayer Pharma AG sued Watson Pharmaceuticals Inc. in Delaware federal court on Friday, alleging the company's application to market a generic oral contraceptive infringes a Merck patent...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

Merck & Cie et al v. Watson Laboratories Inc.

Case Number

1:12-cv-00161

Court

Delaware

Nature of Suit

Patent

Date Filed

February 10, 2012

Recent Articles By Erica

November 20, 2014
Health Care MVP: King & Spalding's Michael Paulhus
November 14, 2014
ACA Contraception Exemption Isn't Burdensome: DC Circ.
November 10, 2014
HHS Issues Special HIPAA Bulletin On Ebola Privacy
November 06, 2014
Expect Another House Vote To Repeal ACA, Boehner Says
October 29, 2014
Hospitals Decry Genentech's Cancer Drug Delivery Overhaul
October 28, 2014
Daschle Leaves DLA Piper For Baker Donelson Policy Group
October 27, 2014
CDC Issues Ebola Monitoring Guidelines Amid Quarantines
October 07, 2014
2nd Circ. Revives Portion Of NY Medicaid Payment Row
October 02, 2014
High Court To Review Medicaid Providers' Right To Sue States
September 30, 2014
Okla. Judge Rejects ACA Tax Subsidies On Federal Exchanges